BSE: BIOCON - Biocon Limited

Rentabilidad a seis meses: +5.38%
Rendimiento de dividendos: +0.42%

Calendario de promoción Biocon Limited

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa Biocon Limited

Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services.

más detalles
The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

ISIN INE376G01013
Industry Biotechnology
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.4195
Дивиденд ао 0.5
Сайт https://www.biocon.com
Цена ао 364.8
Cambio de precio por día: +2.1% (364.8)
Cambio de precio por semana.: -2.59% (382.35)
Cambio de precio por mes: +5.6% (352.7)
Cambio de precio en 3 meses.: +5.69% (352.4)
Cambio de precio en seis meses: +5.38% (353.45)
Cambio de precio por año: +32.57% (280.95)
Cambio de precio en 3 años.: +3.47% (359.95)
Cambio de precio en 5 años.: +30.25% (285.95)
Cambio de precio en 10 años.: 0% (372.45)
Cambio de precio desde principios de año.: +2.1% (364.8)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 2.13 7
P/BV 1.19 9
P/E 29.51 6
EV/EBITDA 16.97 6
Total: 7

Eficiencia

Nombre Significado Calificación
ROA, % 1.89 1
ROE, % 5.43 2
Total: 2.17

Dividendos

Nombre Significado Calificación
Div yield, % 0.4195 1.05
DSI 0.9286 9.29
Total: 2.2

Deber

Nombre Significado Calificación
Debt/EBITDA 6.48 0
Total: 3.4

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 125.31 10
Rentabilidad Ebitda, % 40.16 6
Rentabilidad EPS, % 37.03 5
Total: 5.2
Más detalles

ETF Compartir, % Rentabilidad del año, % Dividendos, %
iShares MSCI India Small-Cap ETF 0.44091 0.4625 0.96163
iShares MSCI Emerging Markets Small-Cap ETF 0.13861 7.67 2.7853
Franklin FTSE India ETF 0.11361 20.52 1.25133
WisdomTree India Earnings Fund 0.03674 5.23 1.65591
JPMorgan ActiveBuilders Emerging Markets Equity ETF 0.03636 9.27 3.1658
SPDR Portfolio Emerging Markets ETF 0.02908 11.59 3.1879
Avantis Responsible Emerging Markets Equity ETF 0.0279 17.6 3.1719
Franklin FTSE Asia ex Japan ETF 0.02659 14.43 2.66768
Dimensional Emerging Markets Value ETF 0.01912 17.07 4.19508
John Hancock Multifactor Emerging Markets ETF 0.01141 4.68 3.42078
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01046 12.46 3.59676
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.01012 2.43 4.35382
Vanguard ESG International Stock ETF 0.01 6.39 3.07501
iShares Core MSCI Total International Stock ETF 0.00917 6.4 3.25258
Avantis Emerging Markets Equity ETF 0.00884 8.77 3.60513
Dimensional Emerging Markets Core Equity 2 ETF 0.00859 15.96 3.34087
Dimensional World ex U.S. Core Equity 2 ETF 0.00222 13.06 3.62488

Supervisor Título profesional Pago año de nacimiento
Mr. Siddharth Mittal BCom, CA, CPA MD, CEO & Director 47.88M 1978 (47 años)
Mr. Saurabh Paliwal Head of Investor Relations N/A
Mr. Mayank Verma Company Secretary & Compliance Officer 5.75M
Ms. Seema Shah Ahuja BA, MBA Global Head of Communications & Corporate Brand N/A 1966 (59 años)
Mr. Peter James Jonathan Bains Group Chief Executive Officer 3.28M 1957 (68 años)
Mr. Arun Gupta Head of Operations N/A
Mr. Atanu Roy Group Chief Information Officer N/A
Ms. Maninder Kapoor Puri Head of Human Resources N/A 1973 (52 año)
Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc. Founder & Executive Chairperson 1953 (72 año)
Mr. Mukesh Kamath Chief Financial Officer

DIRECCIÓN: India, Bengaluru, 20th KM Hosur Road - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.biocon.com